BIPOLAR DISORDER TYPE II: THE RELATIONSHIP BETWEEN INTERSTITIAL NEPHRITIS AND THE USE OF LITHIUM

Autores

  • Thalyta dos Santos Alencar Universidade Evangà©lica de Goiás - UniEVANGà‰LICA
  • Amanda Fernandes Borges de Araújo
  • Leandro Soares Macedo Silva
  • Lylian Machado Palmiere Ribeiro
  • Walter Josà© Bernardes Filho
  • George Martins Ney da Silva Junior

Palavras-chave:

bipolar disorder, lithium, interstitial nephritis, carbamazepine

Resumo

BIPOLAR DISORDER (BD) IS A COMPLEX PSYCHIATRIC DISORDER, CHARACTERIZED BY DRASTIC CHANGES IN MOOD AND BEHAVIORAL DISORDERS, WHICH MAINLY AFFECTS YOUNG WOMEN, ON AVERAGE BETWEEN 25 AND 27 YEARS. IN THE PRESENT REPORT, WE AIMED TO REFER TO THE OCCURRENCE OF INTERSTITIAL NEPHRITIS, CAUSED BY THE TREATMENT OF BD BY LITHIUM. THUS, THE CASE OF A PATIENT ATTENDED IN A PRIVATE OFFICE REPORTING SUICIDAL IDEAS, DIAGNOSED WITH SEVERE DYSPHORIC SYNDROME, IS PRESENTED. SESSIONS OF COGNITIVE-BEHAVIORAL PSYCHOTHERAPY WERE INITIATED, AS WELL AS ITS DRUG TREATMENT, FOLLOWED BY SEVERAL CRISES AND UNSUCCESSFUL ATTEMPTS TO INTRODUCE LITHIUM AS A VIABLE OPTION. HOWEVER, AFTER A DECADE OF TREATMENT, THE PATIENT AGREED TO START ITS USE. EIGHT YEARS LATER, ACUTE INTERSTITIAL NEPHRITIS WAS DIAGNOSED, SECONDARY TO LITHIUM USE, REPLACING IT WITH CARBAMAZEPINE. THE PATIENT CONTINUED HER TREATMENT FOR ANOTHER FOUR YEARS, UNTIL SHE WAS REFERRED TO ANOTHER PROFESSIONAL IN A DIFFERENT LOCATION. MOREOVER, THE FINAL CONSIDERATION OF THE CASE IS THE CONSTANT NEED FOR MEDICAL EVALUATION WHEN NECESSARY THE USE OF SUCH MEDICATIONS, SINCE THE SIDE EFFECTS CAN BE HARMFUL TO PATIENTS.

Referências

ARIAS, F., et al. Bipolar disorder and substance use disorders. Madrid study on the prevalence of dual disorders/pathology. Adicciones, v. 29, n. 3, p. 186-194, 2017.

AUGUSTA DOS REIS, J. et al. Lítio: tratamento de primeira escolha no transtorno bipolar. Revista Científica da Faculdade de Educação e Meio Ambiente, v. 6, n.1, p. 27-37, 2015.

CUNHA, L. C. DA et al. Carbamazepine and carbamazepine-10, 11-epoxide therapeutic drug monitoring and biochemical and hematological evaluation in bipolar disorder outpatients. Research, Society and Development, v. 10, n. 11, p. 1-15, 2021.

MELLO, D. R.; FELIX, G.; SILVEIRA, A. E. A. Impactos metabólicos na nefrotoxicidade por lítio. Revista de extensão e iniciação científica da UniSociesc, v. 8, n. 2, p. 1-15, 2021.

MAGGIO, I. et al. Meningioma: not always a benign tumor. A review of advances in the treatment of meningiomas. CNS Oncology, v. 10, n. 2, p. 1-16, 2021.

MIKLOWITZ, David J. ; JOHNSON, Sheri L. The Psychopathology and Treatment of Bipolar Disorder. Annual Review of Clinical Psychology, v. 2, n. 1, p. 199–235, 2006.

MISSIO, G. et al. Um estudo controlado randomizado comparando lítio mais ácido valproico versus lítio mais carbamazepina em pacientes jovens com transtorno bipolar tipo 1: o estudo LICAVAL. Trials for BMC Medicine, v. 20, n. 608, p. 1-9, 2009.

RAY-GRIFFITH, S. L. et al. Pregnancy and Electroconvulsive Therapy: A Multidisciplinary Approach. The Journal of ECT, v. 32, n. 2, p. 104–112, 2016.

STAHL, S. M. Lítio. In: Fundamentos de Psicofarmacologia de Sthal. 6 ed. São Paulo. Ed. Artmed LTDA, 409-414, 2019.

ZANATELLI, M. M., BRUMATTI, J. I., e ZANATELLI, F. M. Meningioma gigante como causa de alterações psiquiátricas. Arq Bras Neurocir, v. 28, n. 4, p. 170-173, 2009.

Downloads

Publicado

2022-11-30